1.Dose-effect relationship between dexmedetomidine and ropivacaine during pericapsular nerve group block in elderly patients undergoing total hip arthroplasty
Yuanfeng LI ; Pufeng YE ; Guifeng PAN ; Zhenjiang MAI
Chinese Journal of Tissue Engineering Research 2025;29(21):4514-4520
BACKGROUND:Ropivacaine and dexmedetomidine are two commonly used local anesthetic agents and adjuvants in elderly total hip arthroplasty. They provide sedation and analgesic effects during peripheral hip nerve blocks.OBJECTIVE:To explore the dose-effect relationship between dexmedetomidine and ropivacaine in continuous sedation during pericapsular nerve group block in elderly patients undergoing total hip arthroplasty.METHODS:A total of 120 elderly patients who received total hip arthroplasty in Dongguan Hospital,Guangzhou University of Chinese Medicine from January 2021 to January 2023 were selected as study subjects and randomly divided into two groups 1∶1 matching according to propensity matching method. The observation group (n=60) received pericapsular nerve group block by giving 20 mL mixture of ropivacaine and 1 μg/kg dexmedetomidine. The control group (n=60) received received pericapsular nerve group block by giving 20 mL of ropivacaine. The general data,perioperative indexes,postoperative analgesia,hemodynamic indexes,inflammatory factors,stress indexes,postoperative adverse reactions,length of hospital stay,and the occurrence of postoperative complications were compared and analyzed between the two groups. The median effective dose and 95% effective dose concentrations of ropivacaine pericapsular nerve group block were calculated by the Probit method.RESULTS AND CONCLUSION:(1) The postoperative analgesia of the observation group was better than that of the control group,and the visual analog scale score at 6-hour dynamic,12-hour static,12-hour dynamic,24-hour static,24-hour dynamic,48-hour static,48-hour dynamic,as well as the time of first patient-controlled analgesia compression and the number of patient-controlled analgesia compression at 24 and 48 hours postoperatively were statistically different (P<0.05). (2) There were significant differences between the two groups in mean arterial pressure and heart rate at extubation and 12 hours after extubation (P<0.01). (3) The levels of interleukin-6,tumor necrosis factor-α,epinephrine,and noradrenaline in the observation group were significantly lower than those in the control group at 24 and 48 hours after surgery (P<0.01). (4) There was significant difference in the length of hospital stay between the two groups (P<0.01),and no difference was detected in the occurrence of postoperative complications (P>0.05). (5) The median effective dose and 95% effective dose values of dexmedetomidine combined with ropivacaine were 0.164% and 0.188%,respectively,while the median effective dose and 95% effective dose values of ropivacaine alone were 0.194% and 0.276%,respectively. (6) It is concluded that using dexmedetomidine combined with ropivacaine in pericapsular nerve group block can effectively alleviate postoperative analgesia in elderly patients with total hip arthroplasty,help maintain the hemodynamic stability of patients,reduce postoperative inflammation and stress response,and shorten the length of hospital stay. In addition,dexmedetomidine can reduce the dosage of ropivacaine under the condition of effective pericapsular nerve group block reaction.
2.Dose-effect relationship between dexmedetomidine and ropivacaine during pericapsular nerve group block in elderly patients undergoing total hip arthroplasty
Yuanfeng LI ; Pufeng YE ; Guifeng PAN ; Zhenjiang MAI
Chinese Journal of Tissue Engineering Research 2025;29(21):4514-4520
BACKGROUND:Ropivacaine and dexmedetomidine are two commonly used local anesthetic agents and adjuvants in elderly total hip arthroplasty. They provide sedation and analgesic effects during peripheral hip nerve blocks.OBJECTIVE:To explore the dose-effect relationship between dexmedetomidine and ropivacaine in continuous sedation during pericapsular nerve group block in elderly patients undergoing total hip arthroplasty.METHODS:A total of 120 elderly patients who received total hip arthroplasty in Dongguan Hospital,Guangzhou University of Chinese Medicine from January 2021 to January 2023 were selected as study subjects and randomly divided into two groups 1∶1 matching according to propensity matching method. The observation group (n=60) received pericapsular nerve group block by giving 20 mL mixture of ropivacaine and 1 μg/kg dexmedetomidine. The control group (n=60) received received pericapsular nerve group block by giving 20 mL of ropivacaine. The general data,perioperative indexes,postoperative analgesia,hemodynamic indexes,inflammatory factors,stress indexes,postoperative adverse reactions,length of hospital stay,and the occurrence of postoperative complications were compared and analyzed between the two groups. The median effective dose and 95% effective dose concentrations of ropivacaine pericapsular nerve group block were calculated by the Probit method.RESULTS AND CONCLUSION:(1) The postoperative analgesia of the observation group was better than that of the control group,and the visual analog scale score at 6-hour dynamic,12-hour static,12-hour dynamic,24-hour static,24-hour dynamic,48-hour static,48-hour dynamic,as well as the time of first patient-controlled analgesia compression and the number of patient-controlled analgesia compression at 24 and 48 hours postoperatively were statistically different (P<0.05). (2) There were significant differences between the two groups in mean arterial pressure and heart rate at extubation and 12 hours after extubation (P<0.01). (3) The levels of interleukin-6,tumor necrosis factor-α,epinephrine,and noradrenaline in the observation group were significantly lower than those in the control group at 24 and 48 hours after surgery (P<0.01). (4) There was significant difference in the length of hospital stay between the two groups (P<0.01),and no difference was detected in the occurrence of postoperative complications (P>0.05). (5) The median effective dose and 95% effective dose values of dexmedetomidine combined with ropivacaine were 0.164% and 0.188%,respectively,while the median effective dose and 95% effective dose values of ropivacaine alone were 0.194% and 0.276%,respectively. (6) It is concluded that using dexmedetomidine combined with ropivacaine in pericapsular nerve group block can effectively alleviate postoperative analgesia in elderly patients with total hip arthroplasty,help maintain the hemodynamic stability of patients,reduce postoperative inflammation and stress response,and shorten the length of hospital stay. In addition,dexmedetomidine can reduce the dosage of ropivacaine under the condition of effective pericapsular nerve group block reaction.
3.Correlation between biomarker EHD3 and immune cell infiltration in gastric cancer
Yuanyuan WANG ; Ni ZHOU ; Da WANG ; Ping MAI
Journal of Xi'an Jiaotong University(Medical Sciences) 2023;44(3):374-382
【Objective】 To investigate the prognostic role of EHD3 and its association with immune cell infiltration in gastric cancer. 【Methods】 In this study, EHD3 expression was analyzed using RNA sequencing data from Cancer Genome Atlas (TCGA). Differential analysis, functional enrichment, immune infiltration, immune checkpoint exploration, and clinical baseline data analysis were performed. Independent prognostic factors were identified using univariate and multivariate Cox regression analysis; a column diagram model was developed and evaluated using C-index and calibration diagrams. 【Results】 EHD3 was significantly upregulated in STAD and functional enrichment analysis showed that EHD3 expression was associated with immune response, with most immune cells and immune checkpoints positively correlated with their expression. Cox regression showed that EHD3 was an independent prognostic factor in STAD patients (HR=2.112, 95% CI: 1.340-3.327, P=0.001). 【Conclusion】 EHD3 is considered to be a novel prognostic biomarker for STAD patients, and this study provides a potential therapeutic target for STAD treatment.
4.Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor.
Hailing TANG ; Mengjie RUI ; Junhua MAI ; Wei GUO ; Yuhong XU
Acta Pharmaceutica Sinica B 2020;10(3):546-556
Liposomes, as one of the most successful nanotherapeutics, have a major impact on many biomedical areas. In this study, we performed laser scanning confocal microscope (LSCM) and immunohistochemistry (IHC) assays to investigate the intra-tumor transport and antitumor mechanism of GE11 peptide-conjugated active targeting liposomes (GE11-TLs) in SMMC7721 xenograft model. According to classification of individual cell types in high resolution images, biodistribution of macrophages, tumor cells, cells with high epidermal growth factor receptor (EGFR) expression and interstitial matrix in tumor microenvironment, in addition, their impacts on intra-tumor penetration of GE11-TLs were estimated. Type I collagen fibers and macrophage flooded in the whole SMMC7721 tumor xenografts. Tumor angiogenesis was of great heterogeneity from the periphery to the center region. However, the receptor-binding site barriers were supposed to be the leading cause of poor penetration of GE11-TLs. We anticipate these images can give a deep reconsideration for rational design of target nanoparticles for overcoming biological barriers to drug delivery.
5.Clinical efficacy of Frey and Beger procedures for chronic pancreatitis
Bingqing DU ; Yonghua CHEN ; Zhenjiang ZHENG ; Xubao LIU ; Gang MAI
Chinese Journal of General Surgery 2011;26(8):632-634
Objective To analyse clinical efficacy of Frey and Bger procedures for chronic pancreatitis. Methods Clinical data of seventy patients of chronic pancreatitis undergoing Frey (32 cases) and Beger Procedures (38 cases) in our hospital from January 1999 to June 2009 were retrospectively analyzed,the rate of pain relief and endocrine and exocrine function of the pancreas in longterm follow-up were compared with each other. Results Overall perioperative morbidity for Frey group and Beger group was 12. 5% and 7.9% respectively (P =0. 52); Total pain relief rate in long-term follow-up was 96. 8% and 94. 7% respectively (P =0. 57). Postoperative de novo diabetes mellitus was 12. 5% and 21% ( x2 = 0. 90, P = 0. 34), Rate of steatorrhea was 12. 5% and 18.6% respectively ( x2 = 0. 15, P =0. 70). Conclusions Frey and Beger procedures were equally effective in improving symptoms of chronic pancreatitis and there were no significant differences in perioperative morbidity, rate of pain relief and function of endocrine and exocrine of the pancreas.

Result Analysis
Print
Save
E-mail